DiazMeco_Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer_set2
Ontology highlight
ABSTRACT: Identification of phosphopeptides in EZH2 upon PRKCI treatment (kinase). In vitro kinase reactions were performed in buffer containing 25 mM HEPES, 15 mM MgCl2, and 1mM DTT. Two samples were sent to the facility for analysis, EZH2, and EZH2+PRKCI.
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)
SUBMITTER: Maria T. Diaz-Meco Conde
PROVIDER: MSV000094705 | MassIVE | Tue May 07 12:12:00 BST 2024
SECONDARY ACCESSION(S): PXD052092
REPOSITORIES: MassIVE
ACCESS DATA